General Information of Disease (ID: DISO7SQP)

Disease Name West nile virus infection
Synonyms WNV infection
Disease Class 1D46: West nile virus infection
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISO7SQP: West nile virus infection
ICD Code
ICD-11
ICD-11: 1D46
ICD-10
ICD-10: A92.3
Expand ICD-11
'1D46
Expand ICD-10
'A92.3
Expand ICD-9
001,002,003,004,005,006,007,008,009,010,011,012,013,014,015,016,017,018,019,020,021,022,023,024,025,026,027,028,029,030,031,032,033,034,035,036,037,038,039,040,041,042,043,044,045,046,047,048,049,050,051,052,053,054,055,056,057,058,059,060,061,062,063,064,065,066,067,068,069,070,071,072,073,074,075,076,077,078,079,080,081,082,083,084,085,086,087,088,089,090,091,092,093,094,095,096,097,098,099,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117,118,119,120,121,122,123,124,125,126,127,128,129,130,131,132,133,134,135,136,137,138,139,066.4

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
HBV-002 DMJ6NO8 Phase 1 NA [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 4 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
ChimeriVax-West Nile DMXBKIW Discontinued in Phase 2 NA [2]
MGAWN-1 DMJ3AA5 Discontinued in Phase 2 NA [3]
MGVWN-1 DMI74HW Discontinued in Phase 1/2 NA [4]
West Nile virus vaccine DM37OL5 Terminated NA [5]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 3 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
TYT-1 DM7X0UP Investigative NA [6]
VG-WNV DM6J1GV Investigative NA [6]
WNVax DMZ33FH Investigative NA [6]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 ClinicalTrials.gov (NCT00707642) Safety Study of HBV-002 West Nile Vaccine in Healthy Adults. U.S. National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014346)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022810)
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021624)
5 Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development. Expert Rev Vaccines. 2007 Apr;6(2):183-91.
6 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.